All Type of News
Toujeo & Jardiance landed in Samsung Medical Center
22 new pharmaceutical products, such as Sanofi-Aventis’ next-generation basal insulin Toujeo and Boehringer Ingelheim’s Jardiance, succeeded in newly landing in Samsung Medical Center.
According to the industry con...
Novartis Korea still with no apology for rebate crisisNovartis Korea avoided responsibility for the recent rebate crisis instead of making an apology.
Assemblyperson Mi-Hyuk Kwon from The Minjoo Party demanded an apology from CEO ... |
MOHW, “Based on Novartis case, we will conduct administrative inspections on multinational pharmas”
The Ministry of Health and Welfare(MOHW) will conduct administrative inspections related to rebate on multinational pharmaceutical companies.
Minister Jin-Yup Jung of Health and Welfare announced the ministry will c...
“Janssen Korea violated Narcotics Control Law by advertising ‘Concerta’ to public”An argument was made a multinational pharmaceutical company Janssen Korea was confirmed to violate the Narcotics Control Law for conducting marketing campaigns on people to incr... |
Pharma industry on first day to enforce Bribery Prohibition Law
On the 28th, the Bribery Prohibition Law will be actively enforced.
It has been 4 years since the Anti-Corruption and Civil Rights Commission gave an administrative notice for the legislation of the act on August 201...
Rapidly enlarging dementia treatment market, attracting domestic companies too
Encountering the rapid aging society, overcoming dementia for elders has become a huge social issue. An increasing number of dementia patients enlarges its market; thus, the Alzheimer’s disease market accounting for 5...
Will enlargement of companies be a solution to distribution industry’s security issue?
In order to address the security problem, one of the biggest burdens among domestic pharmaceutical distribution companies, it seems enlargement must be proceeded.
This is because securities have naturally disappeare...
Samsung applies for approval of Humira biosimilar
Samsung is about to secure a pipeline with biosimilars of the top 3 ‘TNF-alpha inhibitors.’
After a ‘Enbrel(etanercept)’ similar, ‘Lenflexis,’ and a ‘Remicade(infliximab)’ similar, ‘Brenzys,’ the company filed for a...
‘Pradaxa 75mg’ approval voluntarily withdrawn due to insufficient usage
Boehringer Ingelheim was confirmed to voluntarily withdraw Korean approval of the low volume of its novel oral anticoagulant, ‘Pradaxa(generic name: dabigatran).’ It has been a year since it acquired the approval on A...
‘Kanarb’ shows off in front of circulatory system experts around the world
A Korean new drug Kanarb in the hypertension market is challenging to the global market beyond the Korean market. The drug is expected to be called the first Korean global drug recognized by both of the Korean and for...
Which are outstanding tetravalent vaccines even for the young?
Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer
Who will be the next Pharmaceutical Safety Bureau Director?
Celltrion completes clinical trials for Remsima SC for European approval
Sales listed pharmas made in the first half of the year
April
January
February
March
April
May
June
July
August
September
October
November
December
2025
1950
1951
1952
1953
1954
1955
1956
1957
1958
1959
1960
1961
1962
1963
1964
1965
1966
1967
1968
1969
1970
1971
1972
1973
1974
1975
1976
1977
1978
1979
1980
1981
1982
1983
1984
1985
1986
1987
1988
1989
1990
1991
1992
1993
1994
1995
1996
1997
1998
1999
2000
2001
2002
2003
2004
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
2031
2032
2033
2034
2035
2036
2037
2038
2039
2040
2041
2042
2043
2044
2045
2046
2047
2048
2049
2050
| Sun | Mon | Tue | Wed | Thu | Fri | Sat |
|---|---|---|---|---|---|---|
30 | 31 | 1 | 2 | 3 | 4 | 5 |
6 | 7 | 8 | 9 | 10 | 11 | 12 |
13 | 14 | 15 | 16 | 17 | 18 | 19 |
20 | 21 | 22 | 23 | 24 | 25 | 26 |
27 | 28 | 29 | 30 | 1 | 2 | 3 |
00:00
01:00
02:00
03:00
04:00
05:00
06:00
07:00
08:00
09:00
10:00
11:00
12:00
13:00
14:00
15:00
16:00
17:00
18:00
19:00
20:00
21:00
22:00
23:00
